Gerald T. Proehl
President, CEO and Chairman at Dermata Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2024
5 years of board service in total across 2 boards, counting each seat separately. Longest: Dermata Therapeutics Inc., 2 years.
Dermata Therapeutics Inc.
Director · President, CEO and Chairman
Tenax Therapeutics Inc.
Director
Chief executive roles
Dermata Therapeutics Inc.
· President, CEO and Chairman
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 2025 | Dermata Therapeutics Inc. | Grant or award | +490,196 | — | — |
| Dec 23, 2025 | Dermata Therapeutics Inc. | Grant or award | +122,549 | — | — |
| Jan 21, 2025 | Dermata Therapeutics Inc. | Grant or award | +787,402 | — | — |
| Aug 8, 2024 | Tenax Therapeutics Inc. | Open-market purchase | +1,666 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.